240 related articles for article (PubMed ID: 37046350)
1. Efficacy of mesenchymal stem cell therapy in rodent models of radiation-induced xerostomia and oral mucositis: a systematic review.
Guan Z; Zhang J; Jiang N; Tian M; Wang H; Liang B
Stem Cell Res Ther; 2023 Apr; 14(1):82. PubMed ID: 37046350
[TBL] [Abstract][Full Text] [Related]
2. Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): Study protocol for a phase 1 dose-escalation trial of patients with xerostomia after radiation therapy for head and neck cancer: MARSH: Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction.
Blitzer GC; Rogus-Pulia NM; Mattison RJ; Varghese T; Ganz O; Chappell R; Galipeau J; McDowell KA; Meyers RO; Glazer TA; Kimple RJ
Cytotherapy; 2022 May; 24(5):534-543. PubMed ID: 35183442
[TBL] [Abstract][Full Text] [Related]
3. Genetic modification to induce CXCR2 overexpression in mesenchymal stem cells enhances treatment benefits in radiation-induced oral mucositis.
Shen Z; Wang J; Huang Q; Shi Y; Wei Z; Zhang X; Qiu Y; Zhang M; Wang Y; Qin W; Huang S; Huang Y; Liu X; Xia K; Zhang X; Lin Z
Cell Death Dis; 2018 Feb; 9(2):229. PubMed ID: 29445104
[TBL] [Abstract][Full Text] [Related]
4. Adipose mesenchymal stromal cells minimize and repair radiation-induced oral mucositis.
Maria OM; Shalaby M; Syme A; Eliopoulos N; Muanza T
Cytotherapy; 2016 Sep; 18(9):1129-45. PubMed ID: 27424150
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cell therapy for salivary gland dysfunction and xerostomia: a systematic review of preclinical studies.
Jensen DH; Oliveri RS; Trojahn Kølle SF; Fischer-Nielsen A; Specht L; Bardow A; Buchwald C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):335-342.e1. PubMed ID: 24528792
[TBL] [Abstract][Full Text] [Related]
6. Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients - A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia.
Blitzer GC; Paz C; Glassey A; Ganz OR; Giri J; Pennati A; Meyers RO; Bates AM; Nickel KP; Weiss M; Morris ZS; Mattison RJ; McDowell KA; Croxford E; Chappell RJ; Glazer TA; Rogus-Pulia NM; Galipeau J; Kimple RJ
Radiother Oncol; 2024 Mar; 192():110093. PubMed ID: 38224919
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Stromal/Stem Cell Therapy Improves Salivary Flow Rate in Radiation-Induced Salivary Gland Hypofunction in Preclinical in vivo Models: A Systematic Review and Meta-Analysis.
Carlander AF; Gundestrup AK; Jansson PM; Follin B; Hoeeg C; Kousholt BS; Larsen RT; Jakobsen KK; Rimborg S; Fischer-Nielsen A; Grønhøj C; Buchwald CV; Lynggaard CD
Stem Cell Rev Rep; 2024 May; 20(4):1078-1092. PubMed ID: 38430363
[TBL] [Abstract][Full Text] [Related]
8. Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): A pilot, first-in-human study of interferon gamma-stimulated marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia.
Blitzer GC; Glazer T; Burr A; Gustafson S; Ganz O; Meyers R; McDowell KA; Nickel KP; Mattison RJ; Weiss M; Chappell R; Rogus-Pulia NM; Galipeau J; Kimple RJ
Cytotherapy; 2023 Nov; 25(11):1139-1144. PubMed ID: 37589639
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal/stem cell therapy for radiation-induced salivary gland hypofunction in animal models: a protocol for a systematic review and meta-analysis.
Jansson PM; Lynggaard CD; Carlander AF; Jensen SB; Follin B; Hoeeg C; Kousholt BS; Larsen RT; Grønhøj C; Jakobsen KK; Rimborg S; Fischer-Nielsen A; Menon JML; von Buchwald C
Syst Rev; 2022 Apr; 11(1):72. PubMed ID: 35436971
[TBL] [Abstract][Full Text] [Related]
10. Intraglandular Off-the-Shelf Allogeneic Mesenchymal Stem Cell Treatment in Patients with Radiation-Induced Xerostomia: A Safety Study (MESRIX-II).
Lynggaard CD; Grønhøj C; Christensen R; Fischer-Nielsen A; Melchiors J; Specht L; Andersen E; Mortensen J; Oturai P; Barfod GH; Haastrup EK; Møller-Hansen M; Haack-Sørensen M; Ekblond A; Kastrup J; Jensen SB; von Buchwald C
Stem Cells Transl Med; 2022 May; 11(5):478-489. PubMed ID: 35435231
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of natural-based products for radiation-induced oral mucositis therapy: A systematic review.
Pranadwista ZF; Nur'aeny N
Cancer Treat Res Commun; 2023; 36():100720. PubMed ID: 37209466
[TBL] [Abstract][Full Text] [Related]
12. The role of stem cells in the prevention and treatment of radiation-induced xerostomia in patients with head and neck cancer.
Nevens D; Nuyts S
Cancer Med; 2016 Jun; 5(6):1147-53. PubMed ID: 26880659
[TBL] [Abstract][Full Text] [Related]
13. Manifestations and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy.
Garg AK; Malo M
J Am Dent Assoc; 1997 Aug; 128(8):1128-33. PubMed ID: 9260423
[TBL] [Abstract][Full Text] [Related]
14. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
[TBL] [Abstract][Full Text] [Related]
15. The preventive and therapeutic effect of acupuncture for radiation-induced xerostomia in patients with head and neck cancer: a systematic review.
Zhuang L; Yang Z; Zeng X; Zhua X; Chen Z; Liu L; Meng Z
Integr Cancer Ther; 2013 May; 12(3):197-205. PubMed ID: 22791311
[TBL] [Abstract][Full Text] [Related]
16. First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial.
Grønhøj C; Jensen DH; Glovinski PV; Jensen SB; Bardow A; Oliveri RS; Specht L; Thomsen C; Darkner S; Kiss K; Fischer-Nielsen A; von Buchwald C
Trials; 2017 Mar; 18(1):108. PubMed ID: 28270226
[TBL] [Abstract][Full Text] [Related]
17. Management of oral mucositis in patients who have cancer.
Lalla RV; Sonis ST; Peterson DE
Dent Clin North Am; 2008 Jan; 52(1):61-77, viii. PubMed ID: 18154865
[TBL] [Abstract][Full Text] [Related]
18. Post-radiation xerostomia therapy with allogeneic mesenchymal stromal stem cells in patients with head and neck cancer: study protocol for phase I clinical trial.
Strojan P; Plavc G; Kokalj M; Mitrovic G; Blatnik O; Lezaic L; Socan A; Bavec A; Tesic N; Hartman K; Svajger U
Radiol Oncol; 2023 Dec; 57(4):538-549. PubMed ID: 38038413
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Mesenchymal Stem Cells for Radiation-Induced Xerostomia: A Randomized, Placebo-Controlled Phase 1/2 Trial (MESRIX).
Grønhøj C; Jensen DH; Vester-Glowinski P; Jensen SB; Bardow A; Oliveri RS; Fog LM; Specht L; Thomsen C; Darkner S; Jensen M; Müller V; Kiss K; Agander T; Andersen E; Fischer-Nielsen A; von Buchwald C
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):581-592. PubMed ID: 29678523
[TBL] [Abstract][Full Text] [Related]
20. Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review.
Lovelace TL; Fox NF; Sood AJ; Nguyen SA; Day TA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 May; 117(5):595-607. PubMed ID: 24650370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]